Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Schelker RC"'
Autor:
Schelker RC; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany. roland.schelker@ukr.de.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. roland.schelker@ukr.de.; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. roland.schelker@ukr.de.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. roland.schelker@ukr.de., Fioravanti J; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mastrogiovanni F; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Baldwin JG; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rana N; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Next Generation Sequencing Core, Leibniz Institute for Immunotherapy, Regensburg, Germany., Li P; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Chen P; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Vadász T; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Spolski R; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Heuser-Loy C; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Slavkovic-Lukic D; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Noronha P; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Damiano G; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Raccosta L; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy., Maggioni D; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy., Pullugula S; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Lin JX; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Oh J; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Grandinetti P; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lecce M; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Hesse L; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; University of Regensburg, Regensburg, Germany., Kocks E; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; University of Regensburg, Regensburg, Germany., Martín-Santos A; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Gebhard C; Next Generation Sequencing Core, Leibniz Institute for Immunotherapy, Regensburg, Germany., Telford WG; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ji Y; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Restifo NP; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Russo V; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Rehli M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Next Generation Sequencing Core, Leibniz Institute for Immunotherapy, Regensburg, Germany., Herr W; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; National Center for Tumor Diseases, WERA Site, Würzburg-Erlangen-Regensburg-Augsburg, Germany.; Center for Immunomedicine in Transplantation and Oncology, University Hospital Regensburg, Regensburg, Germany., Leonard WJ; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. leonardw@nhlbi.nih.gov., Gattinoni L; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany. luca.gattinoni@lit.eu.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. luca.gattinoni@lit.eu.; University of Regensburg, Regensburg, Germany. luca.gattinoni@lit.eu.; Center for Immunomedicine in Transplantation and Oncology, University Hospital Regensburg, Regensburg, Germany. luca.gattinoni@lit.eu.
Publikováno v:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Aug 09; Vol. 9 (1), pp. 199. Date of Electronic Publication: 2024 Aug 09.
Autor:
Schelker RC; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. Electronic address: roland.schelker@ukr.de., Gattinoni L; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany; University of Regensburg, Regensburg, Germany; Center for Immunomedicine in Transplantation and Oncology, University Hospital Regensburg, Regensburg, Germany. Electronic address: luca.gattinoni@ukr.de.
Publikováno v:
Immunity [Immunity] 2023 Oct 10; Vol. 56 (10), pp. 2180-2182.
Autor:
Schelker RC; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Kratzer A; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Müller G; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Brochhausen C; Institute of Pathology, University of Regensburg, Regensburg, Germany., Hart C; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Stempfl T; Center of Excellence for Fluorescent Bioanalytics (KFB), University of Regensburg, Regensburg, Germany., Heudobler D; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Moehle C; Center of Excellence for Fluorescent Bioanalytics (KFB), University of Regensburg, Regensburg, Germany., Herr W; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Iberl S; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Grassinger J; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany.; St. Elisabeth Hospital, Straubing, Germany.
Publikováno v:
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 565-576.
Autor:
Schelker RC; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg , Regensburg , Germany., Grube M; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg , Regensburg , Germany., Reichle A; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg , Regensburg , Germany., Wagner B; Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Regensburg , Regensburg , Germany., Herr W; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg , Regensburg , Germany., Evert M; Department of Pathology, University Hospital of Regensburg , Regensburg , Germany., Vogelhuber M; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg , Regensburg , Germany.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Sep; Vol. 60 (9), pp. 2331-2333. Date of Electronic Publication: 2019 Feb 05.
Autor:
Schelker RC; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany.; Department of Hematology & Oncology, St. Elisabeth Hospital Straubing, Straubing, Germany., Herr W; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Grassinger J; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany.; Department of Hematology & Oncology, St. Elisabeth Hospital Straubing, Straubing, Germany.
Publikováno v:
European journal of haematology [Eur J Haematol] 2019 Jul; Vol. 103 (1), pp. 64-66. Date of Electronic Publication: 2019 May 16.
Autor:
Schelker RC; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. Electronic address: roland.schelker@ukr.de., Andrulis M; Department of Pathology, University Hospital of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany., Müller G; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany., Ushmorov A; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany., Hart C; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany., Herr W; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany., Vogelhuber M; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany., Iberl S; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany., Grassinger J; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
Publikováno v:
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2019 May; Vol. 76, pp. 78-81. Date of Electronic Publication: 2019 Feb 20.
Autor:
Schelker RC; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Andorfer K; Department of Ear-Nose-Throat, University Hospital of Regensburg, Regensburg, Germany., Putz F; Department of Nephrology, University Hospital of Regensburg, Regensburg, Germany., Herr W; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany., Jung EM; Department of Radiology, University Hospital of Regensburg, Regensburg, Germany.
Publikováno v:
PloS one [PLoS One] 2019 Apr 11; Vol. 14 (4), pp. e0215178. Date of Electronic Publication: 2019 Apr 11 (Print Publication: 2019).
Autor:
Putz FJ; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany., Verloh N; Department of Radiology and Interdisciplinary Ultrasound Department, University Hospital Regensburg, Regensburg, Germany., Erlmeier A; Department of Radiology and Interdisciplinary Ultrasound Department, University Hospital Regensburg, Regensburg, Germany., Schelker RC; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany., Schreyer AG; Department of Radiology and Interdisciplinary Ultrasound Department, University Hospital Regensburg, Regensburg, Germany., Hautmann MG; Department of Radiotherapy, University Hospital Regensburg, Germany., Stroszczynski C; Department of Radiology and Interdisciplinary Ultrasound Department, University Hospital Regensburg, Regensburg, Germany., Banas B; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany., Jung EM; Department of Radiology and Interdisciplinary Ultrasound Department, University Hospital Regensburg, Regensburg, Germany.
Publikováno v:
Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2019; Vol. 71 (2), pp. 267-276.
Autor:
Schelker RC; Department of Internal Medicine III, Hematology & Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. roland.schelker@ukr.de., Herr W; Department of Internal Medicine III, Hematology & Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Reichle A; Department of Internal Medicine III, Hematology & Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Vogelhuber M; Department of Internal Medicine III, Hematology & Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
Publikováno v:
BMC cancer [BMC Cancer] 2018 Oct 19; Vol. 18 (1), pp. 1000. Date of Electronic Publication: 2018 Oct 19.
Autor:
Schelker RC; a Department of Internal Medicine III, Hematology and Oncology , University Hospital of Regensburg , Regensburg , Germany., Iberl S; a Department of Internal Medicine III, Hematology and Oncology , University Hospital of Regensburg , Regensburg , Germany., Müller G; a Department of Internal Medicine III, Hematology and Oncology , University Hospital of Regensburg , Regensburg , Germany., Hart C; a Department of Internal Medicine III, Hematology and Oncology , University Hospital of Regensburg , Regensburg , Germany., Herr W; a Department of Internal Medicine III, Hematology and Oncology , University Hospital of Regensburg , Regensburg , Germany., Grassinger J; a Department of Internal Medicine III, Hematology and Oncology , University Hospital of Regensburg , Regensburg , Germany.
Publikováno v:
Hematology (Amsterdam, Netherlands) [Hematology] 2018 Jul; Vol. 23 (6), pp. 337-345. Date of Electronic Publication: 2017 Nov 15.